2022
The effect of incarceration on TB treatment outcomes
O Marr J, Gonçalves C, Arakaki-Sanchez D, Pelissari D, Costa F, Croda J, Walter K, Andrews J. The effect of incarceration on TB treatment outcomes. The International Journal Of Tuberculosis And Lung Disease 2022, 26: 252-258. PMID: 35197165, DOI: 10.5588/ijtld.21.0449.Peer-Reviewed Original ResearchConceptsNon-incarcerated individualsTreatment successTreatment outcomesDrug-susceptible TB casesImproved treatment successTB treatment outcomesTB treatment successClinical risk factorsIncarcerated individualsMultivariate logistic regressionGreater treatment successTB casesClinical factorsObserved therapyPoor outcomeTB notificationsRisk factorsElevated riskGreater efficacyLogistic regressionNotifiable diseaseOutcomesIncarcerated populationsVulnerable individualsUse of DOT
2015
Successful Tuberculosis Treatment Outcomes among HIV/TB Coinfected Patients Down-Referred from a District Hospital to Primary Health Clinics in Rural South Africa
Jacobson KB, Moll AP, Friedland GH, Shenoi SV. Successful Tuberculosis Treatment Outcomes among HIV/TB Coinfected Patients Down-Referred from a District Hospital to Primary Health Clinics in Rural South Africa. PLOS ONE 2015, 10: e0127024. PMID: 25993636, PMCID: PMC4438008, DOI: 10.1371/journal.pone.0127024.Peer-Reviewed Original ResearchConceptsTB treatment outcomesTB/HIVTreatment outcomesHIV clinicDistrict hospitalRetained patientsTreatment completionTreatment successRural South AfricaSuccessful tuberculosis treatment outcomeMajor public health threatDrug-susceptible TBHospital HIV clinicLinkage of careTB treatment completionTB treatment initiationTB treatment servicesTuberculosis treatment outcomesHIV/TBBaseline disease severityNew TB casesPrimary health clinicsPrimary care levelSpecific clinical criteriaHigher treatment successChallenges in managing HIV in people who use drugs
Kamarulzaman A, Altice FL. Challenges in managing HIV in people who use drugs. Current Opinion In Infectious Diseases 2015, 28: 10-16. PMID: 25490106, PMCID: PMC4409950, DOI: 10.1097/qco.0000000000000125.Peer-Reviewed Original ResearchMeSH KeywordsAnti-HIV AgentsCoinfectionComorbidityContinuity of Patient CareHealth Services AccessibilityHepatitis CHIV InfectionsHumansMedication AdherenceMental DisordersNeedle-Exchange ProgramsOpiate Substitution TreatmentSocial ClassSubstance Abuse, IntravenousSubstance-Related DisordersTuberculosisConceptsOpioid substitution therapyHepatitis C virusHIV continuumTreatment outcomesImproved ART adherenceInterferon-based regimesTB treatment outcomesHIV treatment outcomesBetter treatment retentionEvidence-based preventionHIV treatment accessHIV-HCVNoninfectious comorbiditiesOST servicesCare retentionART adherenceHIV managementAntiretroviral adherencePsychiatric comorbiditySubstitution therapyHIV treatmentNew diagnostic technologiesC virusClinical managementEarly diagnosis
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply